May
27
8:00 AM08:00

Arrivals and Registration Desk Open

Delegates may pick up their registration kits, badges and other items from the ISSFAL Registration Desk at the MGM Grand Hotel Conference Center.

Sunday is also the day to attend ISSFAL Satellite Sessions also located there. 

Further details will be available for delegates closer to the dates of the meeting.

View Event →
May
27
9:30 AM09:30

Sponsored Satellites AM and PM

MORNING SATELLITE
(9:00 AM - Noon)

An Update on the Role of EPA and DHA for Brain Health
(Sponsored by GOED, Global Organization for EPA and DHA Omega-3s)


LUNCH ON OWN


AFTERNOON SATELLITES
(14:00 PM - 17:30 PM)


Arachidonic and docosahexaenonic acids in infant development
(Sponsored by DSM)

Drug development of Omega-3 Fatty Acids
(Sponsored by the Sancilio & Co.)

View Event →
May
27
2:00 PM14:00

SATELLITE 3: Drug Development of Omega-3 Fatty acids: Does one size fit all?

Sponsored by Sancilio & Co.

2:00 PM    Opening presentation, Introduction, objectives, issues to be addressed
A Daak/A Rabinowicz (Sancilio & Co)

2:15 PM     Terminology
T Thorsteinsson (Sancilio & Co)
 

Session 1:

2:30 PM     Omega-3 fatty acid PK studies: What, where, and when to measure.
K.Stark (University  of Waterloo)

2:50 PM     Bioactive lipids :  LCPUFA and beyond
N. Bazan (Louisiana State University)


3:10 PM     Bioavailability of oral omega-3 fatty acid formulations under various physiological conditions and formulations with enhanced bioavailability.
K Maki (Midwest Biomed Research)


COFFEE BREAK
3.45 – 4.00


SESSION 2:

4:00 PM    Challenges relating to developing Omega-3 as pharmaceutical products
F Sancilio/A Rabinowicz (Sancilio & Co)

4:15 PM Factors influencing apparent ‘failure’ Omega-3 in clinical trials
P Calder (University of Southampton)

4:30 PM Optimal dose selection in specific therapeutic area (SCD)
A Daak (Sancilio & Co)

4:45 PM     FDA requirements for Omega-3 based NDA’s
E Samara (PharmaPolaris)

SESSION 3:

5:00 PM     Recommendations for new guidelines for approval Omega-3 in Pharma applications (Panel Discussion)
Co-Chairs:
T Brenna (University of  Texas)
W Harris (OmegaQuant)

View Event →